Ovid Therapeutics Inc (OVID)

08:03 AM

Janus Henderson Group PLC Acquires Significant Stake in Ovid The - GuruFocus

08:03 AM

Dec 11, 2025

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals By Investing.com - Investing.com South Africa

Dec 11, 2025

Dec 11, 2025

Ovid Therapeutics Stockholders Approve Key Proposals - TipRanks

Dec 11, 2025

Dec 11, 2025

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals - Investing.com

Dec 11, 2025

Dec 11, 2025

Roth Capital Initiates Coverage of Ovid Therapeutics (OVID) with Buy Recommendation - Nasdaq

Dec 11, 2025

Dec 11, 2025

OVID: Roth Capital Initiates Coverage with a "Buy" Rating at $3. - GuruFocus

Dec 11, 2025

Dec 11, 2025

Roth/MKM initiates Ovid Therapeutics stock with Buy rating on epilepsy drug - Investing.com India

Dec 11, 2025

Dec 07, 2025

What analysts say about Ovid Therapeutics Inc stockTrading Volume Surges & Capitalize On Fast Trends - earlytimes.in

Dec 07, 2025

Dec 05, 2025

Will Ovid Therapeutics Inc. stock deliver long term returns - Newser

Dec 05, 2025

Dec 05, 2025

Will Ovid Therapeutics Inc. (1OT) stock see valuation expansionEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser

Dec 05, 2025

Dec 04, 2025

Will Ovid Therapeutics Inc. (1OT) stock gain from lower interest ratesPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Minerva jumps on phase III funding, leading neuro stocks - BioWorld MedTech

Dec 04, 2025

Dec 04, 2025

Will Ovid Therapeutics Inc. stock gain from strong economyDividend Hike & Precise Entry and Exit Recommendations - Newser

Dec 04, 2025

Dec 03, 2025

Will Ovid Therapeutics Inc. (1OT) stock benefit from sector leadershipJuly 2025 Opening Moves & Verified Chart Pattern Signals - Newser

Dec 03, 2025

Dec 03, 2025

Is Ovid Therapeutics Inc. (1OT) stock attractive for growth fundsJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser

Dec 03, 2025

Dec 02, 2025

Ovid Therapeutics appoints Petra Kaufmann as chief medical officer By Investing.com - Investing.com Nigeria

Dec 02, 2025

Dec 02, 2025

Ovid Therapeutics Names Petra Kaufmann Chief Medical Officer - marketscreener.com

Dec 02, 2025

Dec 02, 2025

Ovid Therapeutics appoints Petra Kaufmann as chief medical officer - Investing.com

Dec 02, 2025

Dec 02, 2025

Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer - Enidnews.com

Dec 02, 2025

Dec 02, 2025

How Ovid Therapeutics Inc. (1OT) stock correlates with oil marketsProduct Launch & Real-Time Chart Pattern Alerts - Newser

Dec 02, 2025

Dec 02, 2025

Is Ovid Therapeutics Inc. (1OT) stock dividend growth reliableMarket Trend Review & Free Real-Time Volume Trigger Notifications - Newser

Dec 02, 2025

Dec 01, 2025

IPO Launch: Is Ovid Therapeutics Inc stock positioned well for digital economyWeekly Gains Summary & Weekly Stock Performance Updates - moha.gov.vn

Dec 01, 2025

Nov 27, 2025

November 2025's Top Penny Stock Opportunities - simplywall.st

Nov 27, 2025

Nov 27, 2025

HC Wainwright Has Negative Estimate for OVID FY2025 Earnings - MarketBeat

Nov 27, 2025

Nov 27, 2025

What analysts say about Ovid Therapeutics Inc 1OT stockVolume Profile Analysis & Explosive Profit Growth - earlytimes.in

Nov 27, 2025

Nov 24, 2025

Ovid Therapeutics (OVID): HC Wainwright Raises Price Target to $2.00 | OVID Stock News - GuruFocus

Nov 24, 2025

Nov 24, 2025

HC Wainwright & Co. Maintains Ovid Therapeutics (OVID) Buy Recommendation - Nasdaq

Nov 24, 2025

Nov 21, 2025

Ovid CEO Meg Alexander Takes The Helm In Time To Harvest Growing Blooms - Citeline News & Insights

Nov 21, 2025

Nov 21, 2025

Is Ovid Therapeutics Inc. stock overvalued by current metricsJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Nov 21, 2025

Nov 20, 2025

Equities Analysts Issue Forecasts for OVID Q4 Earnings - MarketBeat

Nov 20, 2025

Nov 20, 2025

Visual trend scoring systems applied to Ovid Therapeutics Inc.Earnings Risk Summary & Detailed Earnings Play Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

What consensus target says about Ovid Therapeutics Inc. (1OT) stock2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Is Ovid Therapeutics Inc. stock cheap at current valuation2025 Market Outlook & Expert Curated Trade Setups - newser.com

Nov 19, 2025

Nov 19, 2025

Regression analysis insights on Ovid Therapeutics Inc. performanceDollar Strength & High Yield Equity Trading Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Ovid Therapeutics Reports Q3 2025 Financial Results - MSN

Nov 19, 2025

Nov 19, 2025

Combining machine learning predictions for Ovid Therapeutics Inc. - newser.com

Nov 19, 2025

Nov 19, 2025

Long term hold vs stop loss in Ovid Therapeutics Inc.2025 Short Interest & Community Trade Idea Sharing - newser.com

Nov 19, 2025

Nov 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Upgraded at Leerink Partnrs - MarketBeat

Nov 19, 2025

Nov 19, 2025

Historical volatility pattern of Ovid Therapeutics Inc. visualizedWeekly Investment Summary & Free High Accuracy Swing Entry Alerts - newser.com

Nov 19, 2025